How do you manage patients with afibrinogenemia? Do you prefer prophylactic or on demand treatment? What doses and what are your fibrinogen target levels?

Also, how do you prevent thromboembolic events in such patients. For example hip replacement surgery (total endoprosthesis).

Regards

Peter